+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Lifestyle Drugs Market by Therapeutic Type (Dermatology, Insomnia, Obesity), Form (Creams, Gels, Oral Syrups), Distribution - Forecast 2024-2030- Product Image
Global Lifestyle Drugs Market by Therapeutic Type (Dermatology, Insomnia, Obesity), Form (Creams, Gels, Oral Syrups), Distribution - Forecast 2024-2030- Product Image
Sale

Global Lifestyle Drugs Market by Therapeutic Type (Dermatology, Insomnia, Obesity), Form (Creams, Gels, Oral Syrups), Distribution - Forecast 2024-2030

  • PDF Icon

    Report

  • 187 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5305529
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Lifestyle Drugs Market size was estimated at USD 20.94 billion in 2023, USD 22.14 billion in 2024, and is expected to grow at a CAGR of 5.82% to reach USD 31.12 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Lifestyle Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Lifestyle Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Lifestyle Drugs Market, highlighting leading vendors and their innovative profiles. These include Alembic Pharmaceuticals Limited, Amgen, Inc., AstraZeneca Plc, Biocon Limited, Cipla Limited, Dr. Reddy's Laboratories Ltd., Eli Lilly and Company, GlaxoSmithKline Plc, Johnson & Johnson Services, Inc., Lupin Limited, Merck KGaA, Novo Nordisk A/S, Pfizer Inc., Teva Pharmaceutical Industries Ltd., The Procter & Gamble Company, and Viatris Inc.

Market Segmentation & Coverage

This research report categorizes the Lifestyle Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Therapeutic Type
    • Dermatology
    • Insomnia
    • Obesity
    • Sexual Dysfunction
    • Smoking
    • Women’s Health
  • Form
    • Creams
    • Gels
    • Oral Syrups
    • Tablets
  • Distribution
    • Hospital Pharmacies
    • Online Channels
    • Retail Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Lifestyle Drugs Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Lifestyle Drugs Market?
  3. What are the technology trends and regulatory frameworks in the Lifestyle Drugs Market?
  4. What is the market share of the leading vendors in the Lifestyle Drugs Market?
  5. Which modes and strategic moves are suitable for entering the Lifestyle Drugs Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Lifestyle Drugs Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Adoption of unhealthy eating habits and sedentary lifestyle
5.1.1.2. Increasing awareness regarding personal fitness and health consciousness
5.1.1.3. Rise in sexual disorders and hormonal imbalance
5.1.2. Restraints
5.1.2.1. High cost of products
5.1.3. Opportunities
5.1.3.1. Increasing R&D for drug developments
5.1.3.2. Rising expenditure on beauty and skin care therapeutics
5.1.4. Challenges
5.1.4.1. Adverse effects associated with the lifestyle drugs
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Lifestyle Drugs Market, by Therapeutic Type
6.1. Introduction
6.2. Dermatology
6.3. Insomnia
6.4. Obesity
6.5. Sexual Dysfunction
6.6. Smoking
6.7. Women’s Health
7. Lifestyle Drugs Market, by Form
7.1. Introduction
7.2. Creams
7.3. Gels
7.4. Oral Syrups
7.5. Tablets
8. Lifestyle Drugs Market, by Distribution
8.1. Introduction
8.2. Hospital Pharmacies
8.3. Online Channels
8.4. Retail Pharmacies
9. Americas Lifestyle Drugs Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Lifestyle Drugs Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Lifestyle Drugs Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Alembic Pharmaceuticals Limited
13.1.2. Amgen, Inc.
13.1.3. AstraZeneca Plc
13.1.4. Biocon Limited
13.1.5. Cipla Limited
13.1.6. Dr. Reddy's Laboratories Ltd.
13.1.7. Eli Lilly and Company
13.1.8. GlaxoSmithKline Plc
13.1.9. Johnson & Johnson Services, Inc.
13.1.10. Lupin Limited
13.1.11. Merck KGaA
13.1.12. Novo Nordisk A/S
13.1.13. Pfizer Inc.
13.1.14. Teva Pharmaceutical Industries Ltd.
13.1.15. The Procter & Gamble Company
13.1.16. Viatris Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. LIFESTYLE DRUGS MARKET RESEARCH PROCESS
FIGURE 2. LIFESTYLE DRUGS MARKET SIZE, 2023 VS 2030
FIGURE 3. LIFESTYLE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. LIFESTYLE DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. LIFESTYLE DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. LIFESTYLE DRUGS MARKET DYNAMICS
FIGURE 7. LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2023 VS 2030 (%)
FIGURE 8. LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
FIGURE 10. LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
FIGURE 12. LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. LIFESTYLE DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. LIFESTYLE DRUGS MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. LIFESTYLE DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. LIFESTYLE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 6. LIFESTYLE DRUGS MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. LIFESTYLE DRUGS MARKET SIZE, BY INSOMNIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. LIFESTYLE DRUGS MARKET SIZE, BY OBESITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. LIFESTYLE DRUGS MARKET SIZE, BY SEXUAL DYSFUNCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. LIFESTYLE DRUGS MARKET SIZE, BY SMOKING, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. LIFESTYLE DRUGS MARKET SIZE, BY WOMEN’S HEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 13. LIFESTYLE DRUGS MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. LIFESTYLE DRUGS MARKET SIZE, BY GELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. LIFESTYLE DRUGS MARKET SIZE, BY ORAL SYRUPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. LIFESTYLE DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 18. LIFESTYLE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. LIFESTYLE DRUGS MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. LIFESTYLE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 31. CANADA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 32. CANADA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 33. CANADA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 34. MEXICO LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 35. MEXICO LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 36. MEXICO LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 44. ASIA-PACIFIC LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 47. AUSTRALIA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 48. CHINA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 49. CHINA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 50. CHINA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 51. INDIA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 52. INDIA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 53. INDIA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 56. INDONESIA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 57. JAPAN LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 58. JAPAN LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 59. JAPAN LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 62. MALAYSIA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 65. PHILIPPINES LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 68. SINGAPORE LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 71. SOUTH KOREA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 74. TAIWAN LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 75. THAILAND LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 76. THAILAND LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 77. THAILAND LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 80. VIETNAM LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 85. DENMARK LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 86. DENMARK LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 87. DENMARK LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 88. EGYPT LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 89. EGYPT LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 90. EGYPT LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 91. FINLAND LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 92. FINLAND LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 93. FINLAND LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 94. FRANCE LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 95. FRANCE LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 96. FRANCE LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 97. GERMANY LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 98. GERMANY LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 99. GERMANY LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 102. ISRAEL LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 103. ITALY LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 104. ITALY LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 105. ITALY LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 108. NETHERLANDS LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 111. NIGERIA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 112. NORWAY LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 113. NORWAY LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 114. NORWAY LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 115. POLAND LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 116. POLAND LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 117. POLAND LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 118. QATAR LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 119. QATAR LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 120. QATAR LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 126. SAUDI ARABIA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 129. SOUTH AFRICA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 130. SPAIN LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 131. SPAIN LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 132. SPAIN LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 135. SWEDEN LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 138. SWITZERLAND LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 139. TURKEY LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 140. TURKEY LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 141. TURKEY LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC TYPE, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM LIFESTYLE DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 148. LIFESTYLE DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 149. LIFESTYLE DRUGS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 150. LIFESTYLE DRUGS MARKET LICENSE & PRICING

Companies Mentioned

  • Alembic Pharmaceuticals Limited
  • Amgen, Inc.
  • AstraZeneca Plc
  • Biocon Limited
  • Cipla Limited
  • Dr. Reddy's Laboratories Ltd.
  • Eli Lilly and Company
  • GlaxoSmithKline Plc
  • Johnson & Johnson Services, Inc.
  • Lupin Limited
  • Merck KGaA
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • The Procter & Gamble Company
  • Viatris Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages187
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 22.14 Billion
Forecasted Market Value ( USD ) by 2030 $ 31.12 Billion
Compound Annual Growth Rate5.8%
Regions CoveredGlobal
No. of Companies Mentioned16

Related Topics

Related Reports

Lifestyle Drugs - Global Strategic Business Report - Product Image

Lifestyle Drugs - Global Strategic Business Report

  • Report
  • 184 Pages
  • Global
From
Global Lifestyle Drugs Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis. - Product Image

Global Lifestyle Drugs Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis.

  • Report
  • 213 Pages
  • Global
From
Lifestyle Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Lifestyle Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 113 Pages
  • Global
From
Global Pharmerging Market by Product (OTC Drugs, Pharmaceuticals), Indication (Cancer & Autoimmune Diseases, Lifestyle Diseases), Distribution - Forecast 2024-2030 - Product Image

Global Pharmerging Market by Product (OTC Drugs, Pharmaceuticals), Indication (Cancer & Autoimmune Diseases, Lifestyle Diseases), Distribution - Forecast 2024-2030

  • Report
  • 191 Pages
  • Global
From
Global Critical Care Therapeutics Market by Drug Class (Albumin, Antithrombin Concentrates, Factor XIII Concentrates), Application (Acute Coronary Syndrome, Atrial Fibrillation, Coronary Angioplasty) - Forecast 2024-2030 - Product Image

Global Critical Care Therapeutics Market by Drug Class (Albumin, Antithrombin Concentrates, Factor XIII Concentrates), Application (Acute Coronary Syndrome, Atrial Fibrillation, Coronary Angioplasty) - Forecast 2024-2030

  • Report
  • 183 Pages
  • Global
From

About the Lifestyle Drugs Market

The Lifestyle Drugs market within the context of Anti-Obesity Drugs is a rapidly growing sector of the pharmaceutical industry. These drugs are designed to help individuals lose weight and maintain a healthy lifestyle. They are typically prescribed by a doctor and can be taken orally or injected. Commonly prescribed drugs include Orlistat, Phentermine, and Liraglutide. These drugs work by suppressing appetite, increasing metabolism, and reducing fat absorption. Additionally, lifestyle drugs can help reduce the risk of developing chronic diseases such as diabetes, heart disease, and stroke. The market for lifestyle drugs is expected to continue to grow as more people become aware of the health benefits associated with them. Additionally, the increasing prevalence of obesity and related health issues is likely to drive demand for these drugs. Some companies in the market include Novo Nordisk, GlaxoSmithKline, Sanofi, and Orexigen Therapeutics. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.